These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 1048989)

  • 21. [Immunosuppressant drugs in dermatology (author's transl)].
    Christeler A; Delacrétaz J
    Ther Umsch; 1979 May; 36(5):456-62. PubMed ID: 451959
    [No Abstract]   [Full Text] [Related]  

  • 22. [Immunosuppressive agents in the treatment of psoriasis].
    Ruszczak Z
    Vestn Dermatol Venerol; 1976 Jan; (1):35-40. PubMed ID: 997862
    [No Abstract]   [Full Text] [Related]  

  • 23. Immunologic suppression by methotrexate in dermatology.
    Barranco VP
    South Med J; 1972 Apr; 65(4):444-5. PubMed ID: 4555011
    [No Abstract]   [Full Text] [Related]  

  • 24. [Use of cytostatic preparations in certain severe dermatoses (psoriasis, pemphigus, hemodermia)].
    Romanenko GF; Verbenko EV; Goncharova LI; Krepker IaB; Ezhov NIa
    Sov Med; 1974 Jul; 0(7):118-21. PubMed ID: 4137488
    [No Abstract]   [Full Text] [Related]  

  • 25. Methotrexate and other chemotherapeutic agents used to treat psoriasis.
    Jeffes EW; Weinstein GD
    Dermatol Clin; 1995 Oct; 13(4):875-90. PubMed ID: 8785891
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Current status of immunosuppressive therapy in non-neoplastic disorders].
    Grob PJ
    Schweiz Med Wochenschr; 1970 Apr; 100(16):703-7. PubMed ID: 4946733
    [No Abstract]   [Full Text] [Related]  

  • 27. [Problems of chronic skin diseases].
    Meinhof W
    Fortschr Med; 1973 May; 91(13):567-9. PubMed ID: 4267075
    [No Abstract]   [Full Text] [Related]  

  • 28. The potential of pharmacogenetics in optimizing the use of methotrexate for psoriasis.
    Warren RB; Griffiths CE
    Br J Dermatol; 2005 Nov; 153(5):869-73. PubMed ID: 16225593
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Immunosuppressive and cytotoxic drugs in dermatology.
    Dantzig PI
    Arch Dermatol; 1974 Sep; 110(3):393-406. PubMed ID: 4141602
    [No Abstract]   [Full Text] [Related]  

  • 30. [Preliminary studies on immunosuppressive therapy of connective tissue disorders].
    Gillardi U; Liso V; Troccoli G
    Haematologica; 1970 Dec; 55(12):759-65. PubMed ID: 5003115
    [No Abstract]   [Full Text] [Related]  

  • 31. [Blood absorption by the skin in patients treated with methotrexate and imuran].
    Kozlowski J; Szyszymar B
    Przegl Dermatol; 1974; 61(5):607-12. PubMed ID: 4422714
    [No Abstract]   [Full Text] [Related]  

  • 32. [Are there indications for cyclosporin A in dermatology?].
    Mensing H
    Hautarzt; 1986 Aug; 37(8):421-3. PubMed ID: 3759450
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Kaposi's sarcoma resolves after sirolimus therapy in a patient with pemphigus vulgaris.
    Saggar S; Zeichner JA; Brown TT; Phelps RG; Cohen SR
    Arch Dermatol; 2008 May; 144(5):654-7. PubMed ID: 18490593
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Treatment of psoriasis. Part 2. Systemic therapies.
    Lebwohl M; Ali S
    J Am Acad Dermatol; 2001 Nov; 45(5):649-61; quiz 662-4. PubMed ID: 11606913
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Etanercept therapy improves symptoms and allows tapering of other medications in children and adolescents with moderate to severe psoriasis.
    Kress DW
    J Am Acad Dermatol; 2006 Mar; 54(3 Suppl 2):S126-8. PubMed ID: 16488325
    [No Abstract]   [Full Text] [Related]  

  • 36. [Comparative study on the treatment of pemphigus].
    De Backer J
    Arch Belg Dermatol Syphiligr; 1971; 27(1):89-98. PubMed ID: 5126851
    [No Abstract]   [Full Text] [Related]  

  • 37. [Therapeutic management of psoriasis].
    Guilhou JJ
    Ann Dermatol Venereol; 1996; 123(4):276-9. PubMed ID: 8763756
    [No Abstract]   [Full Text] [Related]  

  • 38. The action of antimetabolites in the skin: methotrexate for psoriasis.
    Weinstein GD
    Adv Biol Skin; 1972; 12():287-302. PubMed ID: 4579196
    [No Abstract]   [Full Text] [Related]  

  • 39. Folate supplementation during methotrexate therapy for patients with psoriasis.
    Strober BE; Menon K
    J Am Acad Dermatol; 2005 Oct; 53(4):652-9. PubMed ID: 16198787
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The combination of etanercept and methotrexate increases the effectiveness of treatment in active psoriasis despite inadequate effect of methotrexate therapy.
    Zachariae C; Mørk NJ; Reunala T; Lorentzen H; Falk E; Karvonen SL; Johannesson A; Claréus B; Skov L; Mørk G; Walker S; Qvitzau S
    Acta Derm Venereol; 2008; 88(5):495-501. PubMed ID: 18779890
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.